133 related articles for article (PubMed ID: 15328198)
21. Hypoxia enhances MUC1 expression in a lung adenocarcinoma cell line.
Mikami Y; Hisatsune A; Tashiro T; Isohama Y; Katsuki H
Biochem Biophys Res Commun; 2009 Feb; 379(4):1060-5. PubMed ID: 19141292
[TBL] [Abstract][Full Text] [Related]
22. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
23. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer.
Okami J; Simeone DM; Logsdon CD
Cancer Res; 2004 Aug; 64(15):5338-46. PubMed ID: 15289340
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
25. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
Takanami I
Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
[TBL] [Abstract][Full Text] [Related]
27. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
[TBL] [Abstract][Full Text] [Related]
28. [Expression of HIF-1 alpha and its relationship to apoptosis and proliferation in lung cancer].
Fan LF; Diao LM; Chen DJ; Liu MQ; Zhu LQ; Li HG; Tang ZJ; Xia D; Liu X; Chen HL
Ai Zheng; 2002 Mar; 21(3):254-8. PubMed ID: 12451989
[TBL] [Abstract][Full Text] [Related]
29. Role of BNIP3 in proliferation and hypoxia-induced autophagy: implications for personalized cancer therapies.
Azad MB; Gibson SB
Ann N Y Acad Sci; 2010 Oct; 1210():8-16. PubMed ID: 20973794
[TBL] [Abstract][Full Text] [Related]
30. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
31. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
Tickoo SK; Alden D; Olgac S; Fine SW; Russo P; Kondagunta GV; Motzer RJ; Reuter VE
J Urol; 2007 Apr; 177(4):1258-63. PubMed ID: 17382701
[TBL] [Abstract][Full Text] [Related]
33. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S
Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078
[TBL] [Abstract][Full Text] [Related]
34. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
[TBL] [Abstract][Full Text] [Related]
35. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways.
Swinson DE; Jones JL; Cox G; Richardson D; Harris AL; O'Byrne KJ
Int J Cancer; 2004 Aug; 111(1):43-50. PubMed ID: 15185341
[TBL] [Abstract][Full Text] [Related]
37. BNIP3 protects HepG2 cells against etoposide-induced cell death under hypoxia by an autophagy-independent pathway.
Cosse JP; Rommelaere G; Ninane N; Arnould T; Michiels C
Biochem Pharmacol; 2010 Oct; 80(8):1160-9. PubMed ID: 20637734
[TBL] [Abstract][Full Text] [Related]
38. DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Wykoff CC; Gatter KC; Harris AL
J Pathol; 2003 Jun; 200(2):222-8. PubMed ID: 12754744
[TBL] [Abstract][Full Text] [Related]
39. Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas.
Dagnon K; Pacary E; Commo F; Antoine M; Bernaudin M; Bernaudin JF; Callard P
Clin Cancer Res; 2005 Feb; 11(3):993-9. PubMed ID: 15709164
[TBL] [Abstract][Full Text] [Related]
40. [Expression of hypoxia inducible factor-1alpha and BNIP3 in human laryngeal carcinoma and their relationship].
Liu T; Ba Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Feb; 22(3):112-4. PubMed ID: 18476629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
